MedTrace Logo

Hemodynamic Optimisation Guided With Transcranial Doppler in Septic Shock

NCT04398069 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2020-05-21

No results posted yet for this study

Summary

Randomized, controlled, prospective trial, including ICU patients with Sepsis or septic Shock, at the early phase.

patients will be randomized in 2 groups regarding the hemodynamic management and catecholamin doses:

* Group 1: standard hemodynamic goals and catecholamin infusion to achieve: mean arterial pressure \> or equal to 65 mmHg and diastolic arterial pressure \> ou equal to 50 mmHg within the first 60 minutes.
* Group 2: personalized hemodynamic goals and catecholamin infusion until normal transcranial doppler: IP\<1,2.

Conditions

  • Trans Cranial Doppler Ultrasonography in Heamodynamic Optimisation in Septic Shock

Interventions

PROCEDURE

hemodynamic optimisation aiming to achieve normal cerebral perfusion

hemodynamic optimisation aiming to achieve normal cerebral perfusion: titration of catecholamin infusion.

Sponsors & Collaborators

  • Mongi Slim Hospital

    lead OTHER

Principal Investigators

  • Mhamed Sami Mebazaa, Professor · Mongi Slim Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-02
Primary Completion
2020-08-31
Completion
2020-10-30

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04398069 on ClinicalTrials.gov